# 2024-2025 COVID-19 Vaccine

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/2024-2025-covid-19-vaccine
Canonical HTML page: https://getbiobrief.com/entity/2024-2025-covid-19-vaccine

## Recent coverage (1 stories)

### 37.7% Heart Event Drop with COVID Vaccine Opens New Indication Potential
2026-06-28 15:23:49 · Sentiment: Positive · Impact: 7/10 · Sources: 4

The 2024-2025 COVID vaccine reduced MACE by 37.7% in a large VA trial, with even greater benefits in high-risk subgroups, sparking biopharma interest in a cardiovascular indication for mRNA vaccines.
Full story: https://getbiobrief.com/story/covid-vaccine-cardiovascular-indication-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.